Journal of Shandong University (Health Sciences) ›› 2018, Vol. 56 ›› Issue (12): 7-12.doi: 10.6040/j.issn.1671-7554.0.2018.463

Previous Articles    

Expression and prognostic significance of apoptosis antagonizing transcription factor in hepatocellular carcinoma

SHAO Qianqian1, WANG Jingpu2, WANG Qingjie1   

  1. 1. Institute of Basic Medical Sciences, The Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education, Chinese Ministry of Health, Qilu Hospital of Shandong University, Jinan 250012, Shandong, China;
    2. Department of Ultrasound, Longkou Traditional Chinese Medicine Hospital, Longkou 265701, Shandong, China
  • Published:2022-09-27

PDF (PC)

72

Abstract: Objective To analyze the expression and prognostic significance of apoptosis antagonizing transcription factor(AATF)in liver hepatocellular carcinoma(LIHC). Methods The mRNA and protein expressions and location of AATF in LIHC tissues and control tissues were detected with GEPIA and the Human Protein Atlas. The genomic alterations of AATF in LIHC tissues and the protein network diagram associated with AATF protein were assessed with cBioPortal. The effects of AATF on the 5-year survival and overall survival of liver cancer patients were determined with Kaplan-Meier Plotter. The prognostic significance of AATF in LIHC patients was analyzed with Tumor Immune Estimation Resource. Results Compared with the control tissues, the LIHC tissues showed significantly up-regulated mRNA(P<0.05)and protein expressions of AATF. AATF protein was located in the membrane and cytoplasm of LIHC cells. The genomic alterations of AATF had a low incidence in LIHC. The proteins that interacted with AATF included ATM, CHEK2, and so on, which were mainly involved in the regulation of cell cycle, apoptosis, and transcriptional regula- 山 东 大 学 学 报 (医 学 版)56卷12期 -邵倩倩,等. 抗凋亡转录因子在肝细胞肝癌中的表达及预后作用 \=-tion. The mRNA expression of AATF was negatively correlated with the prognosis of LIHC(log-rank P=0.003). Conclusion AATF is highly expressed in LIHC tissues and associated with poor prognosis.

Key words: Apoptosis antagonizing transcription factor, Liver hepatocellular carcinoma, Prognosis, Data analysis

CLC Number: 

  • R735.7
[1] Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma[J]. Lancet, 2012, 379(9822): 1245-1255.
[2] Bruix J, Gores GJ, Mazzaferro V. Hepatocellular carcinoma: clinical frontiers and perspectives[J]. Gut, 2014, 63(5): 844-855.
[3] Altekruse SF, McGlynn KA, Reichman ME. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005[J]. J Clin Oncol, 2009, 27(9): 1485-1491.
[4] Lindfors K, Halttunen T, Huotari P, et al. Identification of novel transcription factor-like gene from human intestinal cells[J]. Biochem Biophys Res Commun, 2000, 276(2): 660-666.
[5] Bruno T, Iezzi S, Fanciulli M. Che-1/AATF: a critical cofactor for both wild-Type- and mutant-p53 proteins[J]. Front Oncol, 2016, 6: 34. doi: 10.3389/fonc.2016.00034.
[6] Di Padova M, Bruno T, De Nicola F, et al. Che-1 arrests human colon carcinoma cell proliferation by displacing HDAC1 from the p21WAF1/CIP1 promoter[J]. J Biol Chem, 2003, 278(38): 36496-36504.
[7] Hopker K, Hagmann H, Khurshid S, et al. AATF/Che-1 acts as a phosphorylation-dependent molecular modulator to repress p53-driven apoptosis[J]. EMBO J, 2012, 31(20): 3961-3975.
[8] Desantis A, Bruno T, Catena V, et al. Che-1-induced inhibition of mTOR pathway enables stress-induced autophagy[J]. EMBO J, 2015, 34(9): 1214-1230.
[9] Tang Z, Li C, Kang B, et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses[J]. Nucleic Acids Res, 2017, 3(45 W1): W98-W102. doi: 10.1093/nar/gkx247.
[10] Uhlen M, Oksvold P, Fagerberg L, et al. Towards a knowledge-based Human Protein Atlas[J]. Nat Biotechnol, 2010, 28(12): 1248-1250.
[11] Uhlen M, Fagerberg L, Hallstrom BM, et al. Proteomics. Tissue-based map of the human proteome[J]. Science, 2015, 347(6220): 1260419. doi: 10.1126/science.1260419.
[12] Uhlen M, Zhang C, Lee S, et al. A pathology atlas of the human cancer transcriptome[J]. Science, 2017, 357(6352): pii: eaan2507. doi: 10.1126/science.aan2507.
[13] Thul PJ, Akesson L, Wiking M, et al. A subcellular map of the human proteome[J]. Science, 2017, 356(6340): pii: eaal3321. doi: 10.1126/science.aal3321.
[14] Cerami E, Gao J, Dogrusoz U, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data[J]. Cancer Discov, 2012, 2(5): 401-404.
[15] Gao J, Aksoy BA, Dogrusoz U, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal[J]. Sci Signal, 2013, 6(269): pl1. doi: 10.1126/scisignal.2004088.
[16] Szasz AM, Lanczky A, Nagy A, et al. Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patients[J]. Oncotarget, 2016, 7(31): 49322-49333.
[17] Li B, Severson E, Pignon JC, et al. Comprehensive analyses of tumor immunity: implications for cancer immunotherapy[J]. Genome Biol, 2016, 17(1): 174.
[18] Li T, Fan J, Wang B, et al. TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells[J]. Cancer Res, 2017, 77(21): e108-e110. doi: 10.1158/0008-5472.CAN-17-0307.
[19] Liu H, Yang C, Lu W, et al. Prognostic significance of glypican-3 expression in hepatocellular carcinoma: a meta-analysis[J]. Medicine(Baltimore), 2018, 97(4): e9702. doi: 10.1097/MD.0000000000009702.
[20] Miki D, Ochi H, Hayes CN, et al. Hepatocellular carcinoma: towards personalized medicine[J]. Cancer Sci, 2012, 103(5): 846-850.
[21] Berger AC, Korkut A, Kanchi RS, et al. A comprehensive pan-cancer molecular study of gynecologic and breast cancers[J]. Cancer Cell, 2018, 33(4): 690-705.e9. doi: 10.1016/j.ccell.2018.03.014.
[22] Liu J, Lichtenberg T, Hoadley KA, et al. An integrated TCGA Pan-cancer clinical data resource to drive high-quality survival outcome analytics[J]. Cell, 2018, 173(2): 400-416. e11. doi: 10.1016/j.cell.2018.02.052.
[23] Passananti C, Floridi A, Fanciulli M. Che-1/AATF, a multivalent adaptor connecting transcriptional regulation, checkpoint control, and apoptosis[J]. Biochem Cell Biol, 2007, 85(4): 477-483.
[24] Passananti C, Fanciulli M. The anti-apoptotic factor Che-1/AATF links transcriptional regulation, cell cycle control, and DNA damage response[J]. Cell Div, 2007, 2: 21. doi: 10.1186/1747-1028-2-21.
[25] Di Certo MG, Corbi N, Bruno T, et al. NRAGE associates with the anti-apoptotic factor Che-1 and regulates its degradation to induce cell death[J]. J Cell Sci, 2007, 120(Pt 11): 1852-1858.
[26] Fanciulli M, Bruno T, Di Padova M, et al. Identification of a novel partner of RNA polymerase II subunit 11, Che-1, which interacts with and affects the growth suppression function of Rb[J]. FASEB J, 2000, 14(7): 904-912.
[27] Bruno T, De Angelis R, De Nicola F, et al. Che-1 affects cell growth by interfering with the recruitment of HDAC1 by Rb[J]. Cancer Cell, 2002, 2(5): 387-399.
[28] Jackson JG,Lozano G. Che-ating death: CHE1/AATF protects from p53-mediated apoptosis[J]. EMBO J, 2012, 31(20): 3951-3953.
[1] ZHENG Su, CHEN Shuhua, LI Hua, DENG Jie, CHEN Chunhong, WANG Xiaohui, FENG Weixing, HAN Xiaodi, ZHANG Yujia, LI Na, LI Mo, FANG Fang. Correlation between EEG variations and BASED evaluation of the efficacy of ACTH treatment in 54 cases of infantile spasms [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 91-96.
[2] WANG Lihui, GAO Min, KONG Beihua. Angiosarcoma of the uterus: a report of 2 cases and literature review [J]. Journal of Shandong University (Health Sciences), 2022, 60(9): 108-112.
[3] HE Shiqing, LI Wanwan, DONG Shuqing, MOU Jingyi, LIU Yuying, WEI Siyu, LIU Zhao, ZHANG Jiaxin. Construction of a prognostic risk model of pyroptosis-related genes in breast cancer based on database [J]. Journal of Shandong University (Health Sciences), 2022, 60(8): 34-43.
[4] ZHANG Yufeng, XU Min, XING Xiuli, PANG Shuguang, HU Keqing. Epidemiological characteristics of 689 patients with non-ST-segment elevation myocardial infarction [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 118-122.
[5] LI Linlin, WANG Kai. Prediction of hepatocellular carcinoma prognostic genes based on bioinformatics [J]. Journal of Shandong University (Health Sciences), 2022, 60(5): 50-58.
[6] CHU Yan, LIU Duanrui, ZHU Wenshuai, FAN Rong, MA Xiaoli, WANG Yunshan, JIA Yanfei. Expressions of DNA methyltransferases in gastric cancer and their clinical significance [J]. Journal of Shandong University (Health Sciences), 2021, 59(7): 1-9.
[7] CHEN Liyu, XIAO Juan, LYU Xianzhong, DUAN Baomin, HONG Fanzhen. Risk factors influencing prognosis of lower extremity deep vein thrombosis in pregnant and parturient women [J]. Journal of Shandong University (Health Sciences), 2021, 59(7): 38-42.
[8] TIAN Yaotian, WANG Bao, LI Yeqin, WANG Teng, TIAN Liwen, HAN Bo, WANG Cuiyan. Machine learning models based on interpretive CMR parameters can predict the prognosis of pediatric myocarditis [J]. Journal of Shandong University (Health Sciences), 2021, 59(7): 43-49.
[9] LI Wanwan, ZHOU Wenkai, DONG Shuqing, HE Shiqing, LIU Zhao, ZHANG Jiaxin, LIU Bin. Construct of a risk assessment model of breast cancer immune-related lncRNAs based on the database information [J]. Journal of Shandong University (Health Sciences), 2021, 59(7): 74-84.
[10] MI Qi, SHI Shuang, LI Juan, LI Peilong, DU Lutao, WANG Chuanxin. Construction of circRNA-mediated ceRNA network and prognostic assessment model for bladder cancer [J]. Journal of Shandong University (Health Sciences), 2021, 59(6): 94-102.
[11] GENG Chen, YANG Yang, ZHAO Yue, LIU Haoran, CHAO Lan. Identification of differentially expressed genes and Wilms tumor-1 expression in adenomyosis [J]. Journal of Shandong University (Health Sciences), 2021, 59(4): 79-86.
[12] LI Xiangqing, YIN Xin, ZHAO Xuelian, ZHAO Peiqing. Expression and clinical significance of circulating CD56bright subset of NK cells in patients with Parkinsons disease [J]. Journal of Shandong University (Health Sciences), 2021, 59(2): 34-40.
[13] ZENG Rui, HU Xinting, YUN Xiaoya, TIAN Zheng, LI Qing, LIU Jie, ZHANG Ya, WANG Xin. Fluorescence in situ hybridization in the diagnosis of 197 cases of chronic lymphocytic leukemia [J]. Journal of Shandong University (Health Sciences), 2021, 59(11): 35-40.
[14] LI Yinglin, SONG Daoqing, XU Zhonghua. Identification of FKBP11 expression in clear cell renal cell carcinoma using bioinformatics analysis [J]. Journal of Shandong University (Health Sciences), 2020, 1(9): 45-51.
[15] SHI Shuang, LI Juan, MI Qi, WANG Yunshan, DU Lutao, WANG Chuanxin. Construction and application of a miRNAs prognostic risk assessment model of gastric cancer [J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 47-52.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd